JCN Newswire Read More Eisai’s Anti-Epileptic Drug Fycompa Approved In China As Monotherapy For Partial-Onset Seizures And Pediatric Indication For Partial-Onset Seizures ruth 2 8 月 3 minutes TOKYO, Aug 2, 2021 – (JC […]
JCN Newswire Read More Eisai: Discovery Research on AMPA-type Glutamate Receptor Antagonist Perampanel Honored With PSJ Award for Drug Research and Development 2021 ruth 26 3 月 5 minutes TOKYO, Mar 26, 2021 – (J […]
JCN Newswire Read More Eisai: Supplementary New Drug Applications for Anti-Epileptic Drug Fycompa as Monotherapy for Partial-Onset Seizures ruth 16 10 月 3 minutes TOKYO, Oct 16, 2020 – (J […]
